Inspiratory Muscle Training for Childhood Asthma
(iPro Trial)
Trial Summary
What is the purpose of this trial?
This is a single-center, randomized, SHAM-controlled, parallel assignment, double-masked,8-week interventional study among children aged 8-17 years (not yet 18 years old) of age with obesity and asthma. (n=60), recruited from Duke Health Center Creekstone, to test the effectiveness of inspiratory muscle rehabilitation (IMR) as an acceptable add-on intervention to reduce dyspnea (feeling short-of-breath or breathless) and to promote greater activity in children with obesity and asthma. Clinic to test the effectiveness of inspiratory muscle rehabilitation (IMR) as an acceptable add-on intervention to reduce dyspnea (feeling short-of-breath or breathless) and to promote greater activity in children with obesity
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, since the study is testing an add-on intervention, it is likely that you can continue your current asthma medications.
What data supports the idea that Inspiratory Muscle Training for Childhood Asthma is an effective treatment?
The available research shows that Inspiratory Muscle Training (IMT) can be effective for children with asthma. Studies indicate that IMT improves muscle strength and helps with breathing, which can reduce asthma symptoms. One study found that IMT improved respiratory functions and muscle strength in children with asthma. Another study showed that combining IMT with exercise training enhanced exercise capacity and asthma control. Overall, these findings suggest that IMT can be a beneficial treatment for managing asthma in children.12345
What safety data exists for inspiratory muscle training in children with asthma?
The available literature on inspiratory muscle training (IMT) in children with asthma suggests that it can improve respiratory muscle strength, endurance, and clinical outcomes. However, there is considerable variability in training methods, protocols, and outcome measures. While studies indicate potential benefits, more research is needed to refine protocols and establish comprehensive safety data.12467
Is Inspiratory Pulmonary Rehabilitation a promising treatment for childhood asthma?
Research Team
Jason Lang, MD
Principal Investigator
Duke University
Eligibility Criteria
This trial is for children aged 8-17 with obesity and mild asthma. They must be on asthma medication, speak/read English, have internet access and a supportive caregiver. Excluded are those with severe respiratory history, pregnancy plans, lung surgery within two years or conditions preventing safe participation.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo inspiratory muscle rehabilitation (IMR) using the PrO2™ device for 8 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Inspiratory Pulmonary Rehabilitation
Inspiratory Pulmonary Rehabilitation is already approved in United States, European Union for the following indications:
- Obesity-related asthma in children
- Chronic obstructive pulmonary disease (COPD)
- Asthma
- Pulmonary hypertension (PH)
- Interstitial lung disease (ILD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
American Lung Association
Collaborator